-
Signature
-
/s/ Darrell Sherman, as Attorney-in-Fact
-
Issuer symbol
-
TMHC
-
Transactions as of
-
11 Feb 2025
-
Net transactions value
-
-$2,881,357
-
Form type
-
4
-
Filing time
-
13 Feb 2025, 18:50:01 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TMHC |
Common Stock |
Options Exercise |
|
+25,218 |
+9.1% |
|
302,147 |
11 Feb 2025 |
Direct |
F1 |
| transaction |
TMHC |
Common Stock |
Tax liability |
$658,464 |
-10,554 |
-3.5% |
$62.39 |
291,593 |
11 Feb 2025 |
Direct |
F2 |
| transaction |
TMHC |
Common Stock |
Award |
$0 |
+90,784 |
+31% |
$0.000000 |
382,377 |
11 Feb 2025 |
Direct |
F3 |
| transaction |
TMHC |
Common Stock |
Tax liability |
$2,222,893 |
-35,629 |
-9.3% |
$62.39 |
346,748 |
11 Feb 2025 |
Direct |
F4 |
| holding |
TMHC |
Common Stock |
|
|
|
|
|
19,211 |
11 Feb 2025 |
By Trust |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
TMHC |
Restricted Stock Units |
Options Exercise |
|
-25,218 |
-100% |
|
0 |
11 Feb 2025 |
Common Stock |
25,218 |
|
Direct |
F1, F6, F7 |
| transaction |
TMHC |
Performance-based restricted stock units |
Award |
|
+90,784 |
|
|
90,784 |
11 Feb 2025 |
Common Stock |
90,784 |
|
Direct |
F8 |
| transaction |
TMHC |
Performance-based restricted stock units |
Options Exercise |
|
-90,784 |
-100% |
|
0 |
11 Feb 2025 |
Common Stock |
90,784 |
|
Direct |
F3, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: